Adriamycin — 2 mg/1 mL, Solution for injection, 1 × 5 mL vial in 1 box

Adriamycin — 2 mg/1 mL, Solution for injection, 1 × 5 mL vial in 1 box

Adriamycin (Doxorubicin Hydrochloride) is a solution for injection for intravenous use. Doxorubicin is an anthracycline topoisomerase II inhibitor indicated: as a component of multiagent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer ( 1.1 ). Supplied as 1 × 5 mL vial in 1 box; NDC 0143-9549-01; manufacturer Hikma Pharmaceuticals USA Inc. Rx only. Store refrigerated, 2° to 8°C (36° to 46°F). Protect from light. Storage of vials of Adriamycin (DOXOrubicin HCl) Injection, USP following reconstitution under refrigerated conditions can result in the formation of a gelled product.

• Active ingredient or product type: DOXORUBICIN HYDROCHLORIDE
• Strength/concentration: 2 mg/1 mL
• Dosage form and route: Solution for injection, Intravenous
• Exact package presentation: 1 × 5 mL vial in 1 box
• NDC/item number: 0143-9549-01
• Manufacturer/labeler: Hikma Pharmaceuticals USA Inc.
• Storage/handling: Store refrigerated, 2° to 8°C (36° to 46°F). Protect from light. Storage of vials of Adriamycin (DOXOrubicin HCl) Injection, USP following reconstitution under refrigerated conditions can result in the formation of a gelled product.
• Status: Rx only

Important safety information: Radiation-induced toxicity can be increased by the administration of doxorubicin.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.